These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11342800)

  • 1. Uric acid and cardiovascular disease: a renal-cardiac relationship?
    Culleton BF
    Curr Opin Nephrol Hypertens; 2001 May; 10(3):371-5. PubMed ID: 11342800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid and cardiovascular risk: What genes can say.
    Kei A; Koutsouka F; Makri A; Elisaf M
    Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29250870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
    Viazzi F; Leoncini G; Ratto E; Pontremoli R
    J Clin Hypertens (Greenwich); 2006 Jul; 8(7):510-8. PubMed ID: 16849905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uric acid--more deleterious than we thought?].
    Høieggen A; Os I; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1330-2. PubMed ID: 15909004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?].
    Petriş A; Cimpoeşu D; Petriş O; Costache I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum uric acid and cardiovascular risk: state of the art and perspectives.
    Fenech G; Rajzbaum G; Mazighi M; Blacher J
    Joint Bone Spine; 2014 Oct; 81(5):392-7. PubMed ID: 24565888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum uric acid. A cardiovascular risk factor?
    Tweeddale MG; Fodor JG
    Nephron; 1979; 23 Suppl 1():3-6. PubMed ID: 471150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid as a cardiovascular risk factor in arterial hypertension.
    Puig JG; Ruilope LM
    J Hypertens; 1999 Jul; 17(7):869-72. PubMed ID: 10419058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
    Soltani Z; Rasheed K; Kapusta DR; Reisin E
    Curr Hypertens Rep; 2013 Jun; 15(3):175-81. PubMed ID: 23588856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered uric acid levels and disease states.
    Kutzing MK; Firestein BL
    J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hyperuricemia and gout in kidney and cardiovascular disease.
    Edwards NL
    Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S13-6. PubMed ID: 18822470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension.
    Maiolino G; Pagnin E; Plebani M; Davis PA; Calò LA
    Int J Cardiol; 2016 Jun; 212():18-9. PubMed ID: 27016704
    [No Abstract]   [Full Text] [Related]  

  • 15. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
    Kanellis J; Feig DI; Johnson RJ
    Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.
    Verdecchia P; Schillaci G; Reboldi G; Santeusanio F; Porcellati C; Brunetti P
    Hypertension; 2000 Dec; 36(6):1072-8. PubMed ID: 11116127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the causes of persistent hyperuricaemia.
    Emmerson BT
    Lancet; 1991 Jun; 337(8755):1461-3. PubMed ID: 1675330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uric acid and cardiorenal risk: marker or cause?].
    Bellomo G; Venanzi S; Timio M
    G Ital Nefrol; 2011; 28(2):157-65. PubMed ID: 21488030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.